Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (7142)	2/24/2025 10:40:51 AM
From: E_K_S	Respond to of 7239

What is the stock you reference?

To: richardred who wrote (7142)	2/24/2025 12:50:47 PM
From: richardred	1 Recommendation Recommended By E_K_S Respond to of 7239

Sorry I forgot the stock symbol ULBI.

To: richardred who wrote (7142)	2/26/2025 10:03:37 AM
From: robert b furman	Respond to of 7239

Yup, I've learned that even a great acquisition, the opportunity for impairments is always something to take advantage of. Write down the blue sky and high priced inventory that was bought. Any CIO learned that at the MBA school. Bob

To: richardred who wrote (7142)	2/26/2025 5:12:22 PM
From: richardred	Read Replies (1) \| Respond to of 7239

Hi Bob, turns out my guess was right. From an earlier press release ULBI said the acquisition was going to be slightly accretive this year. However as you mentioned a impairment charge might be taken against inventory that was acquired? Bringing it’s value down to inventory that might be obsolete? Due to the time required to complete the accounting close and audit of the financial results of Electrochem Solutions, Inc., which the Company acquired on October 31, 2024, Ultralife is reporting fourth quarter results later than it has in the past, in contrast to its established practice of reporting fourth quarter results on the Thursday of the sixth week after year end. finance.yahoo.com